Molecular profiles of small cell lung cancer subtypes: therapeutic implications

Small cell lung cancer (SCLC; accounting for approximately 13%–15% of all lung cancers) is an exceptionally lethal malignancy characterized by rapid doubling time and high propensity to metastasize. In contrast to the increasingly personalized therapies in other types of lung cancer, SCLC is still r...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Ther Oncolytics
Main Authors: Schwendenwein, Anna, Megyesfalvi, Zsolt, Barany, Nandor, Valko, Zsuzsanna, Bugyik, Edina, Lang, Christian, Ferencz, Bence, Paku, Sandor, Lantos, Andras, Fillinger, Janos, Rezeli, Melinda, Marko-Varga, Gyorgy, Bogos, Krisztina, Galffy, Gabriella, Renyi-Vamos, Ferenc, Hoda, Mir Alireza, Klepetko, Walter, Hoetzenecker, Konrad, Laszlo, Viktoria, Dome, Balazs
Format: Artigo
Jezik:Inglês
Izdano: American Society of Gene & Cell Therapy 2021
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7917449/
https://ncbi.nlm.nih.gov/pubmed/33718595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.02.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki